Hale Therapeutics: Funding, Investors & Team (Oct 2026)
Hale Therapeutics, a Philadelphia firm developing a nicotine vaporizer designed to wean smokers and vapers off of nicotine. The product is made to mimic, not interrupt, nicotine users’ regular habits and behavior while reducing their intake.
Hale Therapeutics has raised $200k across 1 funding round on record, the most recent an Angel of $200k announced in Nov 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hale Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Hale Therapeutics Funding Rounds
Hale Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Hale Therapeutics Funding Compared to Other Biotechnology Startups
Hale Therapeutics' latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hale Therapeutics in Biotechnology and Philadelphia
Companies Similar to Hale Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Hale Therapeutics Funding FAQs
What does Hale Therapeutics do?
Hale Therapeutics, a Philadelphia firm developing a nicotine vaporizer designed to wean smokers and vapers off of nicotine. The product is made to mimic, not interrupt, nicotine users’ regular habits and behavior while reducing their intake.
How much funding has Hale Therapeutics raised?
Hale Therapeutics has raised $200k across 1 round on record. The most recent is an Angel of $200k announced in Nov 2021.
When did Hale Therapeutics last raise funding?
Hale Therapeutics' most recent funding round on record is an Angel of $200k, announced in Nov 2021.
Who is the CEO of Hale Therapeutics?
Josh Israel is listed as CEO at Hale Therapeutics.
Where is Hale Therapeutics headquartered?
Hale Therapeutics is based in Philadelphia, Pennsylvania, United States.
How many employees does Hale Therapeutics have?
Hale Therapeutics is in the 11-50 employee band.
How does Hale Therapeutics' funding compare to other Biotechnology startups?
Hale Therapeutics' latest round of $200k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Hale Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hale Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.